This trial will test whether a patient-centered genetic app can increase understanding of, and affective and behavioral responses to, genetic testing. The study hypothesis is that the intervention will be associated with increases in knowledge, decreases in distress, increases in communication with relatives and health care providers, and increases in performance of risk reducing health behaviors.
- Genetic Predisposition
2 Primary · 7 Secondary · Reporting Duration: Baseline - 18 months
Awards & Highlights
2 Treatment Groups
Usual Care Group
1 of 2
1 of 2
400 Total Participants · 2 Treatment Groups
Primary Treatment: MyCancerGene · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What site did they apply to?
|Abramson Cancer Center at the University of Pennsylvania||100.0%|
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Frequently Asked Questions
What are the intended outcomes of this research?
"This trial has two primary objectives: to evaluate patients using the KnowGene Scale, and to measure changes in uncertainty with the Multi-dimensional Impact of Cancer Risk Assessment Questionnaire (MICRA). Secondary evaluation includes assessing shifts in perceived risk, timeline and utility through quantitative scales as well as Yes/No responses for dietary guidelines. The study will span a period of 18 months from baseline." - Anonymous Online Contributor
Are there any vacancies available for participants in this trial?
"According to details provided on clinicaltrials.gov, this study is currently enrolling participants. Initially published on May 3rd 2021, the trial was most recently updated July 11th 2022." - Anonymous Online Contributor
How many participants is the medical trial accepting at this time?
"Affirmative, clinicaltrials.gov has evidence that this research trial is actively recruiting participants. It was initially posted on May 3rd 2021 and the last update occured on July 11th 2022. 400 individuals must be admitted at a single medical centre to meet their recruitment goals." - Anonymous Online Contributor